Magnum Opus 2 International Holdings Ltd 13D and 13G filings for Sorrento Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-01 4:34 pm Sale | 2020-12-31 | 13G | Sorrento Therapeutics, Inc. SRNE | Magnum Opus 2 International Holdings Ltd | 3,344,242 1.300% | -3,487,713 (-51.05%) | Filing |